COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,884 Articles (22,568 medRxiv, 8,316 bioRxiv)

Most recent first Previous |  Page 2826: Articles 28251-28260  | Next

CoV-Seq: SARS-CoV-2 Genome Analysis and Visualization
Liu, B., Liu, K., Zhang, H., Zhang, L., Huang, L.
10.1101/2020.05.01.071050 — Posted: 2020-05-02
Structural and Functional Implications of Non-synonymous Mutations in the Spike protein of 2,954 SARS-CoV-2 Genomes
Nelson-Sathi, S., Perunthottathu K, U., Easwaran, S., Nair, R. R., Joseph, I., Nori, S. R. C., Philip, J. S., Prasad, R., Kolaparamba, K. V., Ramesh, S., Pillai, H., Gosh, S., TR, S. K., Pillai, M. R.
10.1101/2020.05.02.071811 — Posted: 2020-05-02
An artificial intelligence system reveals liquiritin inhibits SARS-CoV-2 by mimicking type I interferon
Zhu, J., Deng, Y.-Q., Wang, X., Li, X.-F., Zhang, N.-N., Liu, Z., Zhang, B., Qin, C., Xie, Z.
10.1101/2020.05.02.074021 — Posted: 2020-05-02 Discussion: Offsite
PSGL-1 blocks SARS-CoV-2 S protein-mediated virus attachment and infection of target cells
He, S., Hetrick, B., Dabbagh, D., Akhrymuk, I. V., Kehn-Hall, K., Freed, E. O., Wu, Y.
10.1101/2020.05.01.073387 — Posted: 2020-05-02
Release of potential pro-inflammatory peptides from SARS-CoV-2 spike glycoproteins in neutrophil-extracellular traps
Blanco-Miguez, A., Sanchez, B.
10.1101/2020.05.02.072439 — Posted: 2020-05-02 Discussion: Onsite | Offsite
Functional pathways in respiratory tract microbiome separate COVID-19 from community-acquired pneumonia patients
Haiminen, N., Utro, F., PARIDA, L.
10.1101/2020.05.01.073171 — Posted: 2020-05-02
Rapid adaptation of SARS-CoV-2 in BALB/c mice: Novel mouse model for vaccine efficacy
Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.-q., Wang, Y., Teng, Y., Zhao, Z., Cui, Y., Li, Y., Li, X.-F., Li, J., Zhang, N., Yang, X., Chen, S., Zhao, G., Wang, X., Luo, D., Wang, H., Yang, X., Li, Y., Han, G., He, Y., Zhou, X., Geng, S., Sheng, X., Shi, B., Sun, S., Qin, C.-F., Zhou, Y.
10.1101/2020.05.02.073411 — Posted: 2020-05-02 Discussion: Onsite
Identification of Drugs Blocking SARS-CoV-2 Infection using Human Pluripotent Stem Cell-derived Colonic Organoids
Duan, X., Han, Y., Yang, L., Nilsson, B., Wang, P., Zhang, T., Wang, X., Xu, D., Xiang, J. Z., uhl, s., Huang, Y., Chen, H., Wang, H., tenOever, B. R., Schwartz, R. E., Ho, D. D., Pan, F. C., Chen, S., Evans, T. R.
10.1101/2020.05.02.073320 — Posted: 2020-05-02 Discussion: Onsite | Offsite
Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.
Shajahan, A., Archer-hartmann, S. A., Supekar, N. T., Gleinich, A. S., Heiss, C., Azadi, P.
10.1101/2020.05.01.071688 — Posted: 2020-05-02 Discussion: Onsite
Performance verification of detecting COVID-19 specific antibody by using four chemiluminescence immunoassay systems
Wan, Y., Li, Z., Wang, K., Li, T., Liao, P.
10.1101/2020.04.27.20074849 — Posted: 2020-05-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).